Literature DB >> 14506048

Virucidal efficacy of soap and water against human immunodeficiency virus in genital secretions.

Jonathan Z Li1, Elizabeth C Mack, Jay A Levy.   

Abstract

A common bar soap and tap water solution was able to demonstrate a 30-fold human immunodeficiency virus (HIV) inactivation and a 57 to 87% reduction in viable peripheral blood mononuclear cells in a mixture of cervicovaginal lavage fluid and seminal fluid. These observations indicate that soap and water might be used to inactivate HIV and HIV-infected cells in genital secretions.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14506048      PMCID： PMC201149          DOI： 10.1128/AAC.47.10.3321-3322.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  13 in total

1.  Risk factors for HIV among prostitutes in Chiangmai, Thailand.

Authors:  T Siraprapasiri; S Thanprasertsuk; A Rodklay; S Srivanichakorn; P Sawanpanyalert; J Temtanarak
Journal:  AIDS       Date:  1991-05       Impact factor: 4.177

2.  Evaluation of an antimicrobial soap formula for virucidal efficacy in vitro against human immunodeficiency virus in a blood-virus mixture.

Authors:  G C Lavelle; S L Gubbe; J L Neveaux; B J Bowden
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

Review 3.  The transmission of AIDS: the case of the infected cell.

Authors:  J A Levy
Journal:  JAMA       Date:  1988-05-27       Impact factor: 56.272

4.  In vitro inactivation of HIV-1 by contraceptive sponge containing nonoxynol-9.

Authors:  B Polsky; P A Baron; J W Gold; J L Smith; R H Jensen; D Armstrong
Journal:  Lancet       Date:  1988-06-25       Impact factor: 79.321

5.  Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition.

Authors:  H L Martin; B A Richardson; P M Nyange; L Lavreys; S L Hillier; B Chohan; K Mandaliya; J O Ndinya-Achola; J Bwayo; J Kreiss
Journal:  J Infect Dis       Date:  1999-12       Impact factor: 5.226

6.  Factors associated with increased levels of human immunodeficiency virus type 1 DNA in semen.

Authors:  C Xu; J A Politch; L Tucker; K H Mayer; G R Seage; D J Anderson
Journal:  J Infect Dis       Date:  1997-10       Impact factor: 5.226

7.  MT-4 plaque formation can distinguish cytopathic subtypes of the human immunodeficiency virus (HIV).

Authors:  M Tateno; J A Levy
Journal:  Virology       Date:  1988-11       Impact factor: 3.616

8.  Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions.

Authors:  A D Hoffman; B Banapour; J A Levy
Journal:  Virology       Date:  1985-12       Impact factor: 3.616

9.  Local synthesis of IgG antibodies to HIV within the female and male genital tracts during asymptomatic and pre-AIDS stages of HIV infection.

Authors:  L Bélec; C Tévi-Bénissan; X S Lu; T Prazuck; J Pillot
Journal:  AIDS Res Hum Retroviruses       Date:  1995-06       Impact factor: 2.205

10.  A comparison of HIV-1 antibody classes, titers, and specificities in paired semen and blood samples from HIV-1 seropositive men.

Authors:  H Wolff; K Mayer; G Seage; J Politch; C R Horsburgh; D Anderson
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992
View more
  2 in total

1.  Effectiveness of Household Disinfection Techniques to Remove SARS-CoV-2 from Cloth Masks.

Authors:  Maria Angélica Monteiro Mello Mares-Guia; Anne Aline Pereira Paiva; Vinicius Motta Mello; Cristiane M Eller; Andreza Lemos Salvio; Felipe F Nascimento; Emanuelle S R F Silva; Vinicius Tadeu Martins Guerra Campos; Ygara da Silva Mendes; Elba Regina Sampaio Lemos; Ivanildo P Sousa; Marco Aurélio Pereira Horta
Journal:  Pathogens       Date:  2022-08-15

2.  Guidelines for Frontline Health Care Staff Safety for COVID-19.

Authors:  Terrance L Baker; Jack V Greiner; Elizabeth Maxwell-Schmidt; P Henri Lamothe; Modesta Vesonder
Journal:  J Prim Care Community Health       Date:  2020 Jan-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.